The Angina Market, which was worth USD 9.56 billion in 2022, is expected to grow to USD 13.66 billion by 2029, at a steady 5.23% CAGR. Angina, caused by insufficient blood flow to the heart muscles, causes chest pain or discomfort. This condition is frequently caused by narrowed arteries that prevent oxygen-rich blood flow. Coronary artery spasm, unstable plaques, decreased heart pumping...

Hemophilia B, characterized by a deficiency in clotting factor IX, presents a challenging yet evolving landscape in the field of hematology. This rare genetic disorder predominantly affects males and necessitates ongoing advancements in treatment modalities to improve patient outcomes worldwide. Dive into comprehensive analysis! Purchase the complete report @ Hemophilia B Market Understanding...